BILOXI, Miss., April 20, 2016 -- The Food and Drug Administration (FDA) has issued an “Import Alert” for farmed shrimp from Malaysia. Of Malaysian shrimp sampled, 32 percent contained illegal and unsafe amounts of antibiotics, including one that has been shown to cause blood disorders and leukemia.
|
|||
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/03bb3834-0cb4-4a24-a962-3a1714fd73d0
Foreign aquaculture operations use antibiotics to treat shrimp’s bacterial infections, which are rampant due to crowded and unsanitary growing conditions. Chloramphenicol, an antibiotic reserved for use treating drug-resistant strains of plague and typhoid fever, is one of the main culprits in detained Malaysian shrimp.
Dr. David Veal, Executive Director of the American Shrimp Processors Association (ASPA), has said, “This is even more evidence that American restaurants, retailers and consumers should be paying attention to the labels on the shrimp they’re buying. When buying American shrimp, consumers can always be confident that Wild American shrimp products meet or exceed the highest standards, which is not the same case with imports.”
The FDA is responsible for ensuring the safety of any food imported from foreign countries. In this case, so much shrimp from peninsular Malaysia has been unfit for consumption that the FDA took extreme measures to keep American consumers safe.
Shrimp is the most popular seafood in the United States, with an average of four pounds eaten per person. 90 percent of those pounds will be from imported shrimp.
An Import Alert means shipments are guilty until proven innocent, and FDA staff can “detain without physical examination,” or refuse to release the shrimp for sale, until the country exporting it can prove beyond a doubt that the product is safe. In 2015, Malaysia exported 17 million pounds of shrimp to the United States.
About the American Shrimp Processors Association: The American Shrimp Processors Association (ASPA), based in Biloxi, Mississippi, was formed in 1964 to represent and promote the interests of the domestic, U.S. wild-caught, warm water shrimp processing industry along the Gulf and South Atlantic with members from Texas to North Carolina. We are the collective voice of the industry, and our focus is to promote the interests of shrimp processors, other segments of the U.S. domestic wild-caught warm water shrimp industry and the general public. More information is available at http://www.americanshrimp.com.
Media Contact: David Veal, Executive Director [email protected] (228) 806-9600


Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Instagram Outage Disrupts Thousands of U.S. Users
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 



